NCT01955538 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Masmas TN, Møller E, Buhmann C, Bunch V, Jensen JH, Hansen TN, Jørgensen LM, Kjaer C, Mannstaedt M, Oxholm A, Skau J, Theilade LA, Worm L, Ekstrøm M
[Health status and degree of traumatisation among newly arrived asylum seeker--secondary publication]. Ugeskr Laeger. 2010 Jan 11;172(2):120-4. Danish.
Olsen DR, Montgomery E, Bøjholm S, Foldspang A
Prevalence of pain in the head, back and feet in refugees previously exposed to torture: a ten-year follow-up study. Disabil Rehabil. 2007 Jan 30;29(2):163-71.

Treatment of Traumatised Refugees: the Effect of Basic Body Awareness Therapy Versus Mixed Physical Activity as add-on Treatment. A Randomised Controlled Trial.

Details for clinical trial NCT01955538

Clinical trial NCT01955538 - References